Welcome to the e-CCO Library!

P061: Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course
Year: 2022
Source: ECCO'22
Authors: Heredia, M.(1);Charrout, M.(2);Klomberg, R.C.W.(3);Aardoom, M.A.(3);Jongsma, M.M.E.(3);Kemos, P.(4);van Haaften, D.H.(1);Tuk, B.(1);van Berkel, L.A.(1);Bley Folly, B.(1);Mahfouz, A.(2,5);Reinders, M.J.T.(2);Ruemmele, F.(6);Croft, N.(4);Escher, J.C.(3);de Ridder, L.(3);Samsom, J.N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P061: Creeping fat contains a unique T-cell compartment with potential impact on intestinal inflammation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. I. Kredel*1, L. J. Jödicke1, A. A. Kuehl1, I. Freise1, J. Gröne2, B. Siegmund1

Created: Friday, 22 February 2019, 9:49 AM
P061: Epigenetic alterations at diagnosis predict susceptibility, prognosis and treatment escalation in inflammatory bowel disease – IBD Character
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Adams A.*1, Kalla R.1, Vatn S.2, Bonfiglio F.3, Nimmo E.1, Kennedy N.1, Ventham N.1, Vatn M.2, Ricanek P.4, Bergemalm D.5, Halfvarson J.5, Söderholm J.6, Pierik M.7, Törkvist L.8, Gomollόn F.9, Gut I.10, Jahnsen J.2, Satsangi J.1 IBD Character Consortium

Created: Wednesday, 20 February 2019, 10:36 AM
P061: Immune cell infiltrations of myenteric plexus in IBD – characterization and implications
Year: 2021
Source: ECCO'21 Virtual
Authors: Wiese, J.J.(1);Fascì , A.(1);Kühl, A.A.(1);Siegmund, B.(1);Prüß, M.S.(1);Schumann, M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P061: Probiotic kimchi prevented colitis-associated cancer
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.B. Hahm1*, Y.M. Han2, J.M. Park2

Created: Thursday, 21 February 2019, 9:14 AM
P061: Response to anti-α4β7 therapy in Ulcerative colitis is associated with lymphoid aggregate attrition through impaired recruitment of naïve lymphocytes
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Canales-Herrerias, P.(1)*;Uzzan*, M.(1);Seki*, A.(1);Czepielewski, R.S.(2);Verstockt, B.(3);Dunn, A.(1);Dai, D.(1);Ko, H.M.(4);Furtado, G.C.(5);Tokuyama, M.(1);Tankelevich, M.(1);Meringer, H.(1);Cossarini, F.(1);Jha, D.(1);Paulsen, J.D.(6);Nakadar, M.Z.(6);Wong, J.(6);Sharma, K.(1);Rosenstein, A.(1);Dawson, T.(7);Singh, H.(1);Lim, J.(8);Lira, S.A.(5);Yajnik, V.(9);Reboldi, A.(10);Petralia, F.(11);Vermeire, S.(3);Polydorides, A.D.(6);Randolph, G.J.(2);Colombel , J.F.(1);Mehandru, S.(1);
Created: Friday, 14 July 2023, 10:48 AM
P061: Succinate promotes EMT in intestinal epithelial cells through SUCNR1: Relevance in fistula development
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Cosin-Roger*1,2, D. Ortiz-Masia3, M. Aragón-Borrego1, L. Gisbert-Ferrándiz1, S. Calatayud1, M. D. Barrachina1

Created: Friday, 22 February 2019, 9:41 AM
P062 Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Becker, M. Wiendl, A. Schulz-Kuhnt, I. Atreya, R. Atreya, M. Neurath, S. Zundler

Created: Thursday, 30 January 2020, 10:12 AM
P062: 31P MRS and MRI phenotyping of muscle metabolic quality in IBD fatigue
Year: 2022
Source: ECCO'22
Authors: Mcging, J.(1,2);Nicholas, R.(2);Serres, S.(3);Greenhaff, P.(3,4,5);Francis, S.(2);Moran, G.W.(1,5);
Created: Friday, 11 February 2022, 3:52 PM
P062: Antibody responses to SARS-CoV-2 vaccination outperform responses induced by natural infection in patients with IBD receiving immunosuppressive medications: a report from the ICARUS-IBD consortium.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: González Cueto, E.(1)*;Matthew, E.(1);Wellens, J.(2,3);Martinez Pazos, V.(4);Thompson, C.(5);Klenerman, P.(1,3);Cadwell, K.(6);Colombel, J.F.(4);Satsangi, J.(3);Wong, S.Y.(4);
Created: Friday, 14 July 2023, 10:48 AM
P062: Critical role of the IL-33/ST2 axis in colitis-associated colorectal cancer
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. R. Lopetuso*1, 2, 3, C. De Salvo3, L. Di Martino3, W. Goodman3, F. Scaldaferri2, A. Gasbarrini2, T. T. Pizarro3

Created: Friday, 22 February 2019, 9:49 AM
P062: Differences in immune cell population subsets in inflammatory bowel disease patients under anti-TNF treatment
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Notararigo*1,2, J. E. Viñuela Roldán3, M. Abanades-Tercero4, J. E. Dominguez-Munoz1, M. Barreiro-de Acosta1

Created: Friday, 22 February 2019, 9:41 AM
P062: Effects of exposure to steroids on the PredictSURE whole blood prognostic assay in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Alsoud, D.(1);Verstockt, S.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Noor, N.(3,4);Verstockt, B.(1,2);Vermeire, S.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P062: Small intestinal lactulose and sucralose hyper-permeability in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A.K. Al-Saffar1,2, A.H. Md.1, G. Hall1, P. Hellström1, D.-L. Webb1*

Created: Thursday, 21 February 2019, 9:14 AM
P062: The narrow spectrum kinase inhibitor TOP1288 demonstrates potent anti-inflammatory effects in a T cell adoptive transfer colitis model through a topical mode of action
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Solanke Y., Foster M., Fyfe M., Rowley A., Sirohi S., Webber S., Walshe C.

Created: Wednesday, 20 February 2019, 10:36 AM
P063 B-cell receptor signalling in lymphoid tissues may be regulated by CEACAM1
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Nagaishi, N. Tsugawa, D. Yamada, T. Watabe, M. Onizawa, M. Watanabe

Created: Thursday, 30 January 2020, 10:12 AM
P063: Dissecting the role of rage in intestinal fibrosis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Speca*1, M. Body-Malapel1, C. Fradin1, M. Djouina1, E. Boulanger1, A.-M. Schmidt2, P. Desreumaux1, C. Vignal1

Created: Friday, 22 February 2019, 9:49 AM
P063: Expression of the coinhibitory receptor TIGIT on memory CD4+ T cells is induced by TCR ligation and retinoic acid co-stimulation and is elicited during microbial colonization of the intestine.
Year: 2022
Source: ECCO'22
Authors: Barendregt, D.(1);Joosse, M.E.(1);van Berkel, L.A.(1);van Schoonhoven, A.(1);Samsom, J.N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P063: Faecal calprotectin as a non-invasive treatment target to predict mucosal healing and histological remission in asymptomatic ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Correia Varela Almeida1*, J.M. Vázquez Morón1, E. Gómez Delgado1, H. Pallarés Manrique1, A. Talavera Fabuel2, A. Bejarano García1

Created: Thursday, 21 February 2019, 9:14 AM
P063: HDAC as versatile regulators of the intestinal epithelial barrier in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Friedrich M., Ganther J., Breiderhoff T., Rosenthal R., Glauben R., Siegmund B.

Created: Wednesday, 20 February 2019, 10:36 AM